Literature DB >> 23087048

Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling.

Humam Kadara1, Li Shen, Junya Fujimoto, Pierre Saintigny, Chi-Wan Chow, Wenhua Lang, Zuoming Chu, Melinda Garcia, Mohamed Kabbout, You-Hong Fan, Carmen Behrens, Diane A Liu, Li Mao, J Jack Lee, Kathryn A Gold, Jing Wang, Kevin R Coombes, Edward S Kim, Waun Ki Hong, Ignacio I Wistuba.   

Abstract

Gene expression alterations in response to cigarette smoke have been characterized in normal-appearing bronchial epithelium of healthy smokers, and it has been suggested that adjacent histologically normal tissue displays tumor-associated molecular abnormalities. We sought to delineate the spatial and temporal molecular lung field of injury in smoker patients with early-stage non-small cell lung cancer (NSCLC; n = 19) who were accrued into a surveillance clinical trial for annual follow-up and bronchoscopies within 1 year after definitive surgery. Bronchial brushings and biopsies were obtained from six different sites in the lung at the time of inclusion in the study and at 12, 24, and 36 months after the first time point. Affymetrix Human Gene 1.0 ST arrays were used for whole-transcript expression profiling of airways (n = 391). Microarray analysis identified gene features (n = 1,165) that were nonuniform by site and differentially expressed between airways adjacent to tumors relative to more distant samples as well as those (n = 1,395) that were significantly altered with time up to 3 years. In addition, gene interaction networks mediated by phosphoinositide 3-kinase (PI3K) and extracellular signal-regulated kinase (ERK)1/2 were modulated in adjacent compared with contralateral airways and the latter network with time. Furthermore, phosphorylated AKT and ERK1/2 immunohistochemical expression were significantly increased with time (nuclear pAKT, P = 0.03; cytoplasmic pAKT, P < 0.0001; pERK1/2, P = 0.02) and elevated in adjacent compared with more distant airways (nuclear pAKT, P = 0.04; pERK1/2, P = 0.03). This study highlights spatial and temporal cancer-associated expression alterations in the molecular field of injury of patients with early-stage NSCLCs after definitive surgery that warrant further validation in independent studies. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23087048      PMCID: PMC3774536          DOI: 10.1158/1940-6207.CAPR-12-0290

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  36 in total

1.  Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer.

Authors:  O AUERBACH; A P STOUT; E C HAMMOND; L GARFINKEL
Journal:  N Engl J Med       Date:  1961-08-10       Impact factor: 91.245

2.  Lung cancer, smoke exposure, and sex.

Authors:  Adi F Gazdar; Michael J Thun
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

3.  Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium.

Authors:  Katrin Susanne Lips; Christopher Volk; Bernhard Matthias Schmitt; Uwe Pfeil; Petra Arndt; Dagmar Miska; Leander Ermert; Wolfgang Kummer; Hermann Koepsell
Journal:  Am J Respir Cell Mol Biol       Date:  2005-04-07       Impact factor: 6.914

4.  EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.

Authors:  Ximing Tang; Hisayuki Shigematsu; B Nebiyou Bekele; Jack A Roth; John D Minna; Waun Ki Hong; Adi F Gazdar; Ignacio I Wistuba
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

5.  Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer.

Authors:  C A Powell; S Klares; G O'Connor; J S Brody
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

6.  Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer.

Authors:  Avrum Spira; Jennifer E Beane; Vishal Shah; Katrina Steiling; Gang Liu; Frank Schembri; Sean Gilman; Yves-Martine Dumas; Paul Calner; Paola Sebastiani; Sriram Sridhar; John Beamis; Carla Lamb; Timothy Anderson; Norman Gerry; Joseph Keane; Marc E Lenburg; Jerome S Brody
Journal:  Nat Med       Date:  2007-03-04       Impact factor: 53.440

7.  Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.

Authors:  I I Wistuba; C Behrens; S Milchgrub; D Bryant; J Hung; J D Minna; A F Gazdar
Journal:  Oncogene       Date:  1999-01-21       Impact factor: 9.867

Review 8.  Lung cancer preneoplasia.

Authors:  Ignacio I Wistuba; Adi F Gazdar
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

9.  Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.

Authors:  S A Belinsky; K J Nikula; W A Palmisano; R Michels; G Saccomanno; E Gabrielson; S B Baylin; J G Herman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

10.  Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression.

Authors:  Jennifer Beane; Paola Sebastiani; Gang Liu; Jerome S Brody; Marc E Lenburg; Avrum Spira
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  20 in total

1.  Genomic variations in the counterpart normal controls of lung squamous cell carcinomas.

Authors:  Dalin Zhang; Liwei Qu; Bo Zhou; Guizhen Wang; Guangbiao Zhou
Journal:  Front Med       Date:  2017-11-28       Impact factor: 4.592

2.  Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer.

Authors:  Humam Kadara; Junya Fujimoto; Suk-Young Yoo; Yuho Maki; Adam C Gower; Mohamed Kabbout; Melinda M Garcia; Chi-Wan Chow; Zuoming Chu; Gabriella Mendoza; Li Shen; Neda Kalhor; Waun Ki Hong; Cesar Moran; Jing Wang; Avrum Spira; Kevin R Coombes; Ignacio I Wistuba
Journal:  J Natl Cancer Inst       Date:  2014-02-22       Impact factor: 13.506

Review 3.  Is surgery still the best management option for early stage NSCLC?

Authors:  Aurel Ottlakan; Nicola Martucci; Gaetano Rocco
Journal:  Transl Lung Cancer Res       Date:  2014-06

4.  Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.

Authors:  Guoying Yu; Jose D Herazo-Maya; Tomoko Nukui; Marjorie Romkes; Anil Parwani; Brenda M Juan-Guardela; Jennifer Robertson; Jack Gauldie; Jill M Siegfried; Naftali Kaminski; Daniel J Kass
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

Review 5.  Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension.

Authors:  Sébastien Bonnet; Steeve Provencher; Christophe Guignabert; Frédéric Perros; Olivier Boucherat; Ralph Theo Schermuly; Paul M Hassoun; Marlene Rabinovitch; Mark R Nicolls; Marc Humbert
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

6.  Transcriptomic evidence of immune activation in macroscopically normal-appearing and scarred lung tissues in idiopathic pulmonary fibrosis.

Authors:  Irina G Luzina; Mariah V Salcedo; Mónica L Rojas-Peña; Anne E Wyman; Jeffrey R Galvin; Ashutosh Sachdeva; Andrew Clerman; June Kim; Teri J Franks; Edward J Britt; Jeffrey D Hasday; Si M Pham; Allen P Burke; Nevins W Todd; Sergei P Atamas
Journal:  Cell Immunol       Date:  2018-01-03       Impact factor: 4.868

7.  Transforming Cancer Prevention through Precision Medicine and Immune-oncology.

Authors:  Thomas W Kensler; Avrum Spira; Judy E Garber; Eva Szabo; J Jack Lee; Zigang Dong; Andrew J Dannenberg; William N Hait; Elizabeth Blackburn; Nancy E Davidson; Margaret Foti; Scott M Lippman
Journal:  Cancer Prev Res (Phila)       Date:  2016-01

8.  Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma.

Authors:  Jacob Kantrowitz; Ansam Sinjab; Li Xu; Tina L McDowell; Smruthy Sivakumar; Wenhua Lang; Sayuri Nunomura-Nakamura; Junya Fukuoka; Georges Nemer; Nadine Darwiche; Hassan Chami; Arafat Tfayli; Ignacio I Wistuba; Paul Scheet; Junya Fujimoto; Avrum E Spira; Humam Kadara
Journal:  Cancer Prev Res (Phila)       Date:  2018-01-30

Review 9.  Update in Lung Cancer 2014.

Authors:  Avrum Spira; Balazs Halmos; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2015-08-01       Impact factor: 21.405

10.  Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer.

Authors:  Jun-Chieh J Tsay; Benjamin G Wu; Michelle H Badri; Jose C Clemente; Nan Shen; Peter Meyn; Yonghua Li; Ting-An Yie; Tenzin Lhakhang; Evan Olsen; Vivek Murthy; Gaetane Michaud; Imran Sulaiman; Aristotelis Tsirigos; Adriana Heguy; Harvey Pass; Michael D Weiden; William N Rom; Daniel H Sterman; Richard Bonneau; Martin J Blaser; Leopoldo N Segal
Journal:  Am J Respir Crit Care Med       Date:  2018-11-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.